News
Moving biomedical discoveries from federal laboratories into real-world use depends on productive partnerships, but increasingly those partnerships must also account for research security, data protection and national security risks. At Innovation for Impact: A National Security Technology Transfer

In Merck KGaA v. Integra Lifesciences I, Ltd., 125 S. Ct. 2372 (Jun. 13, 2005), the Supreme Court considered the scope of the exemption from patent infringement embodied in 35 U.S.C. § 271(e)(1). Under §271(e)(1), also referred to as the safe harbor provision, "[i]t shall not be an act of